Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Heron Therapeutics (DE:AXD2)
FRANKFURT:AXD2
Heron Therapeutics (AXD2) Ownership - Who Owns Heron Therapeutics?
2 Followers
Heron Therapeutics (AXD2) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
1.61% Other Institutional Investors
98.39% Public Companies and
Individual Investors
The ownership structure of Heron Therapeutics (DE:AXD2) stock is a mix of institutional, retail and individual investors. Approximately 1.61% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 98.39% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 21, 2023 | William Forbes Evp, Chief Development Officer | Bought | $27250 |
| Nov 20, 2023 | William Forbes Evp, Chief Development Officer | Bought | $46500 |
| Nov 17, 2023 | Craig Collard Ceo,director | Bought | $136500 |
| Nov 17, 2023 | Ira Duarte Evp & Cfo | Bought | $74800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $477 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 177,989 | Insider | ― | 420,410 | |
| 52,032 | Insider | ― | 122,900 | |
| 5,821,098 | Insider | ― | 13,749,433 | |
| 2,640 | Insider | ― | 6,236 | |
| 46,648 | Insider | ― | 110,183 | |
| 28,330 | Insider | ― | 66,915 | |
| 1,100 | Insider | ― | 2,598 | |
| 2,683 | Insider | ― | 6,337 | |
| 2 | Institution | ― | 5 | |
| 3,798,633 | Institution | ― | 9,599,146 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,480,430 | Institution | ― | 11,322,047 | |
| 350,000 | Institution | ― | 884,450 | |
| 366,052 | Institution | ― | 925,013 | |
| 2,012,442 | Institution | ― | 5,085,441 | |
| 604,526 | Institution | ― | 1,527,637 | |
| 105,767 | Institution | ― | 267,273 | |
| 1,977 | Institution | ― | 4,996 | |
| 644 | Institution | ― | 1,627 | |
| 727,424 | Institution | ― | 1,838,200 | |
| 32,969 | Institution | ― | 83,313 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Heron Therapeutics (DE:AXD2)?
According to the latest TipRanks data, approximately 1.61% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 98.39% is held by retail investors.
What percentage of Heron Therapeutics (DE:AXD2) stock is held by institutional investors?
According to the latest TipRanks data, approximately 1.61% of Heron Therapeutics (DE:AXD2) stock is held by institutional investors.
What percentage of Heron Therapeutics (DE:AXD2) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.39% of Heron Therapeutics (DE:AXD2) stock is held by retail investors.
Who owns the most shares of Heron Therapeutics (DE:AXD2)?
Barry Quart owns the most shares of Heron Therapeutics (DE:AXD2).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.